Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible?

Related Articles Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? Oncology. 2017;92(1):1-2 Authors: Markman M PMID: 27923224 [PubMed – indexed for MEDLINE]
Origen: Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? – PubMed

Etiquetas:

orixwp

This information box about the author only appears if the author has biographical information. Otherwise there is not author box shown. Follow YOOtheme on Twitter or read the blog.